New York Genome Center-founded Gencove has added $3m from investors including Alexandria Venture Investments to bring its genomics testing kit to new markets.

Gencove, a US-based genome sequencing platform developer spun out of biomedical research facility New York Genome Center, secured $3m on Wednesday in a round featuring Alexandria Venture Investments. The deal, led by venture firm Spero Ventures, also featured Third Kind Venture Capital, Version One Ventures and Burst Capital.¬†Alexandria Real Estate Equities is the strategic VC…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.